The Presence of Prostate-specific Antigen-related Genes in Primates and the Expression of Recombinant Human Prostate-specific Antigen in a Transfected Murine Cell Line

Cancer Research

Volumn 55, Issue 11, 1995, Pages 2455-2462

  Karr, Joan F ^a   Kantor, Judith A ^a   Hand, Patricia Horan ^a   Eggensperger, Diane L ^a   Schlom, Jeffrey ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; HUMAN; IMMUNOTHERAPY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; SPECIES DIFFERENCE; TUMOR GROWTH; TUMOR MODEL;

ADENOCARCINOMA; ANIMAL; BASE SEQUENCE; CELL DIVISION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION; GENOME; HUMAN; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MOLECULAR SEQUENCE DATA; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029024694     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Catalona, W. J., Smith, D. S., Ratliff, T. L., and Basier, J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. J. Am. Med. Assoc., 270: 948–954, 1993.
2. Wang, M. C., Valenzueia, L. A., Murphy, G. P., and Chu, T. M. Purification of a human prostate specific antigen. Invest. Urol., 17: 159–163, 1979.
3. Papsidero, L. D., Kuriyama, M., Wang, M. C., Horoszewicz, J., Leong, S. S., Valenzueia, L., Murphy, G. P., and Chu, T. M. Prostate antigen: a marker for human prostate epithelial cells. J. Natl. Cancer Inst. 66: 37–41, 1981.
4. Lilja, H. A Kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J. Clin. Invest., 76: 1899–1903, 1985.
5. Watt, K. W. K., Lee, P-J., MTimkulu, T., Chan, W-P., and Loor, R. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc. Natl. Acad. Sci. USA, 83: 3166–3170, 1986.
6. Nadji, M., Tabei, S. Z., Castro, A., Chu, T. M., Murphy, G. P., Wang, M. C., and Morales, A. R. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer (Phila.), 48: 1229–1232, 1981.
7. Kuriyama, M., Wang, M. C., Papsidero, L. D., Killian, C. S., Shimano, T., Valenzueia, L., Nishiura, T., Murphy, G. P., and Chu, T. M. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res., 40: 4658–4662, 1980.
8. Babaian, R. J., Miyashita, H., Evans, R. B., and Ramirez, E. I. The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age. J. Urol., 147: 837–840, 1992.
9. Oesterling, J. E. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J. Urol., 145: 907–923, 1991.
10. Abi-Aad, A. S., MacFarlane, M. T., Stein, A., and deKernion, J. B. Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. J. Urol., 147: 952–955, 1992.
11. Miller, J. I., Ahmann, F. R., Drach, G. W., Emerson, S. S., and Bottaccini, M. R. The clinical usefulness of serum prostate specific antigen after hormonal therapy of metastatic prostate cancer. J. Urol., 147: 956–961, 1992.
12. Huang, C-L., Brassil, D., Rozzell, M., Schellhammer, P. F., and Wright, G. L., Jr. Comparison of prostate secretory protein with prostate specific antigen and prostatic acid phosphatase as a serum biomarker for diagnosis and monitoring patients with prostate carcinoma. Prostate, 23: 201–212, 1993.
13. Meyers, F. J., Denardo, S. J., Macey, D., White, R. D., and Unger, M. Development of monoclonal antibody imaging of metastatic prostatic carcinoma. Prostate, 14: 209–220, 1989.
14. Gleave, M., Hsieh, J-T., Gao, C., von Eschenbach, A. C., and Chung, L. W. K. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Cancer Res., 51: 3753–3761, 1991.
15. Ito, Y. Z., and Nakazato, Y. A new serially transplantable human prostatic cancer (Honda) in nude mice. J. Urol., 132: 384–387, 1984.
16. Wright, G. L., Jr., Haley, C. L., Csapo, Z., and van Steenbrugge, G. J. Immunohis-tochemical evaluation of the expression of prostate tumor-association markers in the nude mouse human prostate carcinoma heterotransplant lines PC-82, PC-EW, and PC-EG. Prostete, 17: 301–316, 1990.
17. Newhall, K. R., Isaacs, J. T., and Wright, G. L., Jr. Dunning rat prostate tumors and cultured cell lines fail to express human prostate carcinoma-associated antigens. Prostate, 17: 317–325, 1990.
18. Dubé, J. Y., Lazure, C., and Tremblay, R. R. Dog prostate arginine esterase is related to human prostate specific antigen. Clin. Invest. Med., 9: 51–54, 1986.
19. Krawiec, D. R., and Heflin, D. Study of prostatic disease in dogs: 177 cases (1981–1986). J. Am. Vet. Med. Assoc., 200: 1119–1122, 1992.
20. McEntee, M., Isaacs, W., and Smith, C. Adenocarcinoma of the canine prostate: immu-nohistochemical examination for secretory antigens. Prostate, 11: 163–170, 1987.
21. Fox, B. A., Spiess, P. J., Kasid, A., Puri, R., Mulé, J. J., Weber, J. S., and Rosenberg, S. A. In vitro and in vivo antitumor properties of a T-cell clone generated from murine tumor-infiltrating lymphocytes. J. Biol. Response Mod., 9: 499–511, 1990.
22. Horoszewicz, J. S., Leong, S. S., Chu, T. M., et al. The LNCaP cell line: a new model for studies on human prostatic carcinoma. In: G. P. Murphy (ed.), Models for Prostate Cancer, pp. 115–132. New York: A. R. Liss, 1980.
23. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980–990, 1989.
24. Hesdorffer, C., Markowitz, D., Ward, M., and Bank, A. Somatic gene therapy. Hematol. Oncol. Clin. North Am., 5: 423–432, 1991.
25. Davis, L. G., Dibner, M. D., and Battey, J. F. Basic Methods in Molecular Biology. New York: Elsevier, 1986.
26. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
27. Hand, P. H., Robbins, P. F., Salgaller, M. L., Poole, D. J., and Schlom, J. Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies. Cancer Immunol. Immunother., 36: 65–75, 1993.
28. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
29. Robbins, P. F., Kantor, J. A., Salgaller, M., Hand, P. H., Fernsten, P. D., and Schlom, J. Transduction and expression of the human carcinoembryonic antigen gene in a murine colon carcinoma cell line. Cancer Res., 51: 3657–3662, 1991.
30. Rosenberg, S. A., Spiess, P., and Lafreniere, R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Washington DC), 233: 1318–1321, 1986.
31. Lundwall, Å., and Lilja, H. Molecular cloning of human prostate specific antigen cDNA. FEBS Lett., 214: 317–322, 1987.
32. Schedlich, L. J., Bennetts, B. H., and Morris, B. J. Primary structure of a human glandular kallikrein gene. DNA, 6: 429–437, 1987.
33. Fukushima, D., Kitamura, N., and Nakanishi, S. Nucleotide sequence of cloned cDNA for human pancreatic kallikrein. Biochemistry, 24: 8037–8043, 1985.
34. Baker, A. R., and Shine, J. Human kidney kallikrein: cDNA cloning and sequence analysis. DNA, 4: 445–450, 1985.
35. Lundwall, Å. Characterization of the gene for prostate-specific antigen, a human glandular kallikrein. Biochem. Biophys. Res. Commun., 161: 1151–1159, 1989.
36. Evans, B. A., Yun, Z. X., Close, J. A., Tregear, G. W., Kitamura, N., Nakanishi, S., Callen, D. F., Baker, E., Hyland, V. J., Sutherland, G. R., and Richards, R. I. Structure and chromosomal localization of the human renal kallikrein gene. Biochemistry, 27: 3124–3129, 1988.
37. Riegman, P. H. J., Vlietstra, R. J., van der Korput, J. A. G. M., Romijn, J. C., and Trapman, J. Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene. Biochem. Biophys. Res. Commun., 159: 95–102, 1989.
38. Henttu, P., and Vihko, P. cDNA coding for the entire human prostate specific antigen shows high homologies to the human tissue kallikrein genes. Biochem. Biophys. Res. Commun., 160: 903–910, 1989.
39. Gauthier, E. R., Chapdelaine, P., Tremblay, R. R., and Dubé, J. Y. Characterization of rhesus monkey prostate specific antigen cDNA. Biochim. Biophys. Acta, 1174: 207–210, 1993.
40. Aumüller, G., Seitz, J., Lilja, H., Abrahamsson, P-A., von der Kammer, H., and Scheit, K-H. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate, 17: 31–40, 1990.
41. 1rantichymotrypsin. Clin. Chem., 37: 1618–1625, 1991.
42. Christensson, A., Laurell, C-B., and Lilja, H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur. J. Biochem., 194: 755–763, 1990.
43. Christensson, A., and Lilja, H. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen. Eur. J. Biochem., 220: 45–53, 1994.
44. Lilja, H. Structure, function, and regulation of the enzyme activity of prostate-specific antigen. World J. Urol., 11: 188–191, 1993.
45. Gleave, M. E., Hsieh, J-T., Wu, H-C., von Eschenbach, A. C., and Chung, L. W. K. Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors. Cancer Res. 52: 1598–1605, 1992.
46. Chu, T. M., Kuriyama, M., Johnson, E., Papsidero, L. D., Killian, C. S., Murphy, G. P., Wang, M. C. Circulating antibody to prostate antigen in patients with prostate cancer. Transplant. Proc., 16: 481–485, 1984.
47. Yang, N. Endogenous antibody to prostate-specific antigen in women. Clin. Chem., 34: 647–648, 1988.
48. Astles, R., and Miller, W. G. Endogenous antibodies to prostate specific antigen interfere in competitive RIA’s. Clin. Chem., 36: 1049, 1990.